These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27185539)

  • 21. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.
    Fu M; Perlman M; Lu Q; Varga C
    J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase separation kinetics in amorphous solid dispersions upon exposure to water.
    Purohit HS; Taylor LS
    Mol Pharm; 2015 May; 12(5):1623-35. PubMed ID: 25853391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities of Single-Particle Growth Rates in Buried Versus Exposed Ritonavir Crystals within Amorphous Solid Dispersions.
    Griffin SR; Takanti N; Sarkar S; Song Z; Vogt AD; Danzer GD; Simpson GJ
    Mol Pharm; 2020 Dec; 17(12):4564-4571. PubMed ID: 33151697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.
    LaFountaine JS; Jermain SV; Prasad LK; Brough C; Miller DA; Lubda D; McGinity JW; Williams RO
    Eur J Pharm Biopharm; 2016 Apr; 101():72-81. PubMed ID: 26861929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.
    Miyazaki T; Aso Y; Yoshioka S; Kawanishi T
    Int J Pharm; 2011 Apr; 407(1-2):111-8. PubMed ID: 21277962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Polymers on the Physical and Chemical Stability of Spray-dried Amorphous Solid Dispersion: Dipyridamole Degradation Induced by Enteric Polymers.
    Peng T; She Y; Zhu C; Shi Y; Huang Y; Niu B; Bai X; Pan X; Wu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2620-2628. PubMed ID: 29916195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Water Sorption and Crystallization in ASDs 2: Modeling Long-Term Stabilities.
    Grönniger B; Fritschka E; Kimpe K; Singh A; Sadowski G
    Mol Pharm; 2024 Jun; 21(6):2908-2921. PubMed ID: 38743928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
    Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
    Miller DP; Lechuga-Ballesteros D
    Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.
    Wegiel LA; Zhao Y; Mauer LJ; Edgar KJ; Taylor LS
    Pharm Dev Technol; 2014 Dec; 19(8):976-86. PubMed ID: 24192454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
    Konno H; Taylor LS
    J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine.
    Strydom S; Liebenberg W; Yu L; de Villiers M
    Int J Pharm; 2009 Sep; 379(1):72-81. PubMed ID: 19540323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical stability and recrystallization kinetics of amorphous ibipinabant drug product by fourier transform raman spectroscopy.
    Sinclair W; Leane M; Clarke G; Dennis A; Tobyn M; Timmins P
    J Pharm Sci; 2011 Nov; 100(11):4687-99. PubMed ID: 21681752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.